The downside of Mounjaro: hair loss and other side effects

In recent years interest in GLP-1 agonist weight-loss drugs has grown explosively. Mounjaro (active ingredient: tirzepatide) - like Ozempic - was originally developed to treat type 2 diabetes, but because of its remarkable weight-reducing effect it is increasingly used for weight loss as well.

Alongside the fast results, however, more and more users report a side effect that can be off-putting for many: significant hair loss.

Why can Mounjaro cause hair loss?

It is important to state that the drug itself does not directly cause the hair loss. The underlying problem is the extremely rapid weight loss, which puts serious strain on the body. When the body suddenly sheds a large amount of weight, it prioritizes vital functions (organ function, metabolism, immunity), and hair growth - as a non-vital process - is pushed into the background, slows down or even stops.

This condition is medically called telogen effluvium, which can be triggered by major physical or emotional stress (rapid weight loss, childbirth, surgery, febrile illness). In this case hairs enter the resting (telogen) phase en masse and then fall out all at once 2-3 months later. The Mounjaro patient information leaflet also warns that hair loss can be a common side effect.

Other similar products can also cause hair loss

Mounjaro is not unique in this respect. Other drugs in the GLP-1 agonist group - such as Ozempic (semaglutide) or Wegovy - can also be linked to hair loss. With these products as well, hair loss can develop through a similar mechanism, the stress effect caused by rapid weight loss. It is therefore worth being aware that the appearance of the side effect depends not on the active ingredient but on the pace of weight loss.

How can hair loss be stopped?

The treatment of hair loss always depends on what type of hair loss it is. Fortunately telogen effluvium is a reversible condition: once the trigger (in this case rapid weight loss) ceases, hair loss usually settles on its own within 3-6 months.

The available treatment options, however, differ depending on the type and cause of the hair loss we are dealing with

Treatment	Application	Characteristics
Minoxidil	Topical solution applied to the scalp	Stimulates hair growth; available without a prescription
Finasteride	Oral medication	Men only! Inhibits the effect of the hormone that triggers hair loss
PRP therapy	Injection of platelet-rich plasma made from your own blood	Stimulates the function of the hair follicles
Laser therapy	Laser treatment of the scalp	Painless, stimulates cell division
Oxygen therapy	A combination of medical oxygen, vitamins and minerals	Improves the condition of the scalp

The key to successful treatment is early intervention and accurate diagnosis of the type of hair loss.

Women and men: not every therapy is equally effective

It is particularly important that not every therapy is suitable for both women and men - indeed, some agents may be expressly contraindicated.

• In men, androgenetic alopecia (hereditary, male-pattern baldness) is the most common, characterized by a progressive deterioration of hair follicle function. In this case finasteride can be an effective drug treatment, as it inhibits the production of the hormone (DHT) that triggers hair loss.
• In women, hair loss is often caused by hormonal changes (e.g. menopause), when the decrease in estrogen levels upsets the balance of the sex hormones. Finasteride cannot be used in women, as it can cause serious side effects, especially at childbearing age.

In addition, the assessment of a hair transplant also differs between the sexes.

The final solution: hair transplant - for whom and when

During a hair transplant (FUE technique), your own hair follicles are transplanted from the donor area at the back of the head to the areas lacking hair. This procedure can be truly effective when the extent of the hair loss is in proportion to the amount of hair that can be transplanted.

In men a hair transplant often brings a spectacular change after just a few months, and restoring the frontal hairline is the main goal.

In women, however, the situation is different:

In women, reaching the final result can take up to a year. A common problem is that the gap between the possibilities of the donor area and the need for coverage is so large that the surgery may not lead to satisfaction.

In addition, the possible haircut needed for the surgery or possible hair loss after surgery must be weighed separately.

Important: a hair transplant is worth having only when hair loss has stabilized. If hair loss is still in an active phase (for example telogen effluvium), the transplanted hair may also fall out, so the procedure will not lead to a result.

The use of Mounjaro and other GLP-1 agonists can result in serious weight loss, but rapid weight reduction can lead to hair loss caused by telogen effluvium. The good news is that this condition is reversible: by slowing the pace of weight loss, adequate nutrition and, if needed, targeted therapies (minoxidil, I-PRF, laser treatment), hair usually grows back.

However, not every therapy can be used in both sexes - finasteride is made specifically for men and its use is prohibited in women. A hair transplant can serve as a final solution, but only in stable, non-progressive hair loss, and in women it requires a more cautious assessment.

Always consult your treating physician before starting any therapy, and if you experience hair loss while using Mounjaro, be sure to discuss the options with your doctor!